ISRCTN13467677Completed未知
Financial incentives for hypertension control among community-based hypertensive populations: a multi-center, randomized controlled trial
Shengjing Hospital of China Medical University0 sites207 target enrollmentStarted: May 16, 2019Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 207
Study Overview
Brief Summary
2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35862120/ (added 22/07/2022) 2020 Protocol article in https://pubmed.ncbi.nlm.nih.gov/32014046/ (added 10/06/2024)
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •1. Aged 35 - 75 years
- •2. Uncontrolled hypertensive patients (SBP/DBP = 140/90mmHg)
- •3. Have WeChat and use skillfully
- •4. Local residents, who live in local places for more than 12 months
- •5. Voluntarily joined and signed informed consents
Exclusion Criteria
- •1. Pregnant women or women who are planning to become pregnant in the next year
- •2. Plans to move from the neighborhood in the next year
- •3. Malignant tumors or severe liver, kidney dysfunction
- •4. Can not be proficient in using WeChat
- •5. Secondary hypertension patients
- •6. Disagree to participate in the study or cannot give the informed consent
Investigators
Similar Trials
Completed
Not Applicable
ENhanced Control of Hypertension ANd Thrombolysis strokE stuDyISRCTN82387104The George Institute for Global Health (Australia)4,587
Completed
Not Applicable
A novel approach to treatment of hypertension in diabetic patients - A multicenter, double-blind, randomised study comparing the efficacy of combination therapy of Eprosartan versus Ramipril with low-dose Hydrochlorothiazide and Moxonidine on blood pressure levels in patients with hypertension and associated diabetes mellitus type 2 - rationale and design.Essential Hypertension grade I and IICirculatory SystemHypertensionISRCTN55725285Solvay Pharmaceuticals (Germany)
Completed
Not Applicable
Monetary Incentives and Intrinsic Motivation to Sustain Hypertension ControlHypertensionNCT01402453University of California, Los Angeles207
Active, not recruiting
Not Applicable
Behavioral Economics to Improve Antihypertensive Therapy AdherenceMedication AdherenceHypertensionNCT04029883Cedars-Sinai Medical Center60
Active, not recruiting
Not Applicable
Personalized management of high blood pressure in Anhui, ChinaCirculatory SystemHypertensionISRCTN10999269ational Natural Science Foundation of China3,420